SCHEMBL6206712

SCHEMBL6206712

NCC(c1ccc(Cl)c(Cl)c1)N1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 9/20 0.62
SLC6A3 Q01959 8/20 0.62
SLC6A4 P31645 7/20 0.62
RPS6KB1 P23443 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
ADAM17 P78536 1/20 0.43
KMT2A Q03164 1/20 0.43
MCL1 Q07820 1/20 0.43
TACR1 P25103 1/20 0.43
DPP4 P27487 1/20 0.42
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8784361 0.85 TACR1 (0.57) SLC6A2SLC6A3SLC6A4RPS6KB1TACR1
SCHEMBL7312748 0.82 SLC6A2 (0.68) SLC6A2SLC6A3SLC6A4SMN1; SMN2MEN1
SCHEMBL16461973 0.81 RPS6KB1 (0.50) RPS6KB1KMT2APOLB
SCHEMBL10399500 0.80 SLC6A3 (0.58) SLC6A2SLC6A3SLC6A4SMN1; SMN2MEN1
SCHEMBL3669763 0.79 RPS6KB1 (0.49) RPS6KB1ALDH1A1KMT2APOLB
SCHEMBL5559565 0.79 SLC6A2 (0.45) SLC6A2SLC6A3SLC6A4TACR1DPP4
SCHEMBL16461381 0.77 RPS6KB1 (0.50) SLC6A2SLC6A3SLC6A4RPS6KB1SMN1; SMN2
SCHEMBL14775283 0.77 SLC6A2 (1.00) SLC6A2SLC6A3SLC6A4TACR1
SCHEMBL6231996 0.77 OPRL1 (0.57)
SCHEMBL14775500 0.76 SLC6A2 (1.00) SLC6A2SLC6A3SLC6A4TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709375-B1 Therapeutic heterocycles ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
US-6147083-A NOVEL SUBSTITUTED 1,2-ETHANEDIAMINE DERIVATIVES WHICH ANTAGONIZE THE PHARMACOLOGICAL ACTIONS OF THE ENDOGENOUS NEUROPEPTIDE TACHYKININS KNOWN AS NEUROKININS, USEFUL FOR THE TREATMENT OF ASTHMA, ETC. ZENECA LIMITED (GB) 2000-11-14 US disclosed
US-5998444-A ANTIASTHMA AGENTS; NEUROKININ ANTAGONIST ZENECA LTD. (GB) 1999-12-07 US disclosed
WO-1998017696-A1 DISPERSANTS AND DISPERSANT VISCOSITY INDEX IMPROVERS FROM SELECTIVELY HYDROGENATED POLYMERS MOBIL OIL CORPORATION (US) 1998-04-30 WO disclosed
US-5710169-A NEUROKININ ANTAGONISTS; ANTIHISTAMINES, BRONCHODILATOR AGENTS; ASTHMA ZENECA LIMITED (GB) 1998-01-20 US disclosed
EP-0709375-A2 Therapeutic heterocycles ZENECA LIMITED (GB) 1996-05-01 EP disclosed